Search

everythinglearnresearchcommunity

for

Search:↓

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

4-aminopyridine, a FDA-approved drug, speeds up skin wound healing and tissue regeneration.

4-aminopyridine helps skin wounds heal faster and better.

Nerves and chemicals in the body can affect hair growth and loss.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Sunlight worsens hair loss; protect scalp.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.